68Ga-NNS309 Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1: 2

Top Sponsors

Novartis Pharmaceuticals2

Indications

Lung Cancer2
Breast Cancer2
Cancer2
HR+/HER2- Lobular Breast Cancer (BC)1
HR+/HER2- Ductal Breast Cancer (BC)1

Other2 trials

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Phase 1

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.